CBG is an agonist of α2-adrenoceptor and the serotonin 1A receptors (5-HT1A), which are involved in regulating mood, anxiety, and depression (Cascio et al., 2010; Mendiguren et al., 2023; Rock et al., 2011). The gene discussed is HTR1A; the disease is depressive symptom measurement.